Antibodies for PTMScan™
Cell Signaling Technology developed Motif Antibodies to enable focused analysis of regulatory post-translational modifications (PTMs). We use these in the form of custom PTMScan License/IAP Bead Products in our PTMScan Services, and we provide these products with a Per-Use License to enable our customers to perform PTMScan proteomics in-house.
Whether your research objective is to understand specific serine/threonine kinase families or kinome branches, global tyrosine phosphorylation, protein acetylation or ubiquitin-mediated signaling, our PTMScan™ Services and PTMScan License/IAP Beads products provide powerful tools for in-depth proteomic analysis of regulatory PTMs.
PTMScan – PhosphoScan®, UbiScan™, AcetylScan™ – is the most effective strategy for PTM proteomics, and our 18 PTMScan License/IAP Bead products (see below) are custom, optimized reagents for immunoaffinity purification (IAP) of serine/threonine and tyrosine phosphopeptides, acetylated peptides and ubiquitin-tagged peptides. PTMScan is a method that combines Motif Antibody-based IAP and tandem mass spectrometry to generate focused and quantitative results about proteins on which PTMs perform key regulatory functions. It is the PTM-specificity of our Motif Antibodies that makes PTMScan Services and Per-Use Licensing of PTMScan License/IAP Bead products the standards for proteomic analysis of regulatory signaling.
Antibodies for PTMScan™
| Target | Motif IAP Bead | Consenus Site | Study # | Cell or Tissue Type | Modified Peptides Identified |
|---|---|---|---|---|---|
| Target | Motif IAP Bead | Consenus Site | Study # | Cell or Tissue Type | Modified Peptides Identified |
KinomeView™ & Serine/Threonine PhosphoScan® |
|||||
| Phospho-Akt Substrate | 1978 | (R)XRXXpS/pT | 2964 | MKN-45 (gastric cancer) | 174 | PDF | XLS |
| Phospho-Akt Substrate | 1979 | RXRXXpS/pT | 3230 | Mouse brain | 237 | PDF | XLS |
| Phospho-(Ser/Thr) ATM/ATR Substrate | 1980 | pS/pTQ | 3235 | Jurkat (T cell acute lymphoblastic leukemia) | 342 |
| Phospho-(Ser/Thr) ATM/ATR Substrate | 1993 | pS/pTQG | 2796 | Jurkat (T cell acute lymphoblastic leukemia) | 414 |
| Phospho-(Ser) CDKs Substrate | 1981 | K/RpSPXK/R | 2724 | K562 (chronic myelogenous leukemia) | 305 | PDF | XLS |
| Phospho-(Thr) CK Substrate | 1994 | pS/pTD/EXD/E | 2921 | Mouse liver | 497 | PDF | XLS |
| Phospho-MAPK/CDK Substrates | 1982 | PXpSP, pSPXR/K | 1915 | Kyse140 (esophageal carcinoma) | 459 | PDF | XLS |
| Phospho-MAPK Substrates | 1983 | PXpTP | 1826 | SEM (B cell acute lymphoblastic leukemia) | 260 | PDF | XLS |
| Phospho-PKA Substrate | 1984 | K/RK/RXpS/pT | 2929 | Jurkat (T cell acute lymphoblastic leukemia) | 205 |
| Phospho-(Ser) PKC Substrate | 1985 | K/RXpSXK/R | 2628 | K562 (chronic myelogenous leukemia) | 152 |
| Phospho-(Ser/Thr) PKD Substrate | 1986 | LXRXXpS/pT | 2901 | Mouse brain | 276 |
| Phospho-(Ser/Thr) PDK1 Docking Motif | 1992 | F/YpS/pTF/Y | 3121 | Mouse brain | 424 |
| Phospho-(Thr) PLK Binding Motif A7907 | 1995 | SpTP | 1665 | H1703 (non-small cell lung cancer) | 538 | PDF | XLS |
| Phospho-Thr-Pro Motif | 1996 | pTP | 3481 | Jurkat (T cell acute lymphoblastic leukemia) | 578 | PDF | XLS |
| Phospho-Thr-Pro-Glu Motif | 1987 | pTPE | 2544 | Jurkat (T cell acute lymphoblastic leukemia) | 465 | PDF | XLS |
| Phospho-Thr-X-Arg Motif | 1988 | pTXR | 2655 | K562 (chronic myelogenous leukemia) | 82 | PDF | XLS |
Tyrosine PhosphoScan® |
|||||
| Phosphotyrosine (P-Tyr-100) | 1991 | pY | 8809 | H3255 (non-small cell lung cancer) | 930 | PDF | XLS |
UbiScan® |
|||||
| Ubiquitin Branch | 1990 | K-ε-GG | 3115 | Mouse liver | Ubiquitinated peptides identified: 798 |
AcetylScan® |
|||||
| Acetylated-Lysine | 1989 | Ac-K | 2292 | Jurkat (T cell acute lymphoblastic leukemia) | Acetylated peptides identified: 283 |